Abstract
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and can profoundly affect the academic achievement, well-being, and social interactions of children; the American Academy of Pediatrics first published clinical recommendations for the diagnosis and evaluation of ADHD in children in 2000; recommendations for treatment followed in 2001.
- Copyright © 2011 by the American Academy of Pediatrics
In this issue
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Jump to section
- Article
- Abstract
- INTRODUCTION
- METHODOLOGY
- ABOUT THIS GUIDELINE
- KEY ACTION STATEMENTS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF ADHD IN CHILDREN AND ADOLESCENTS
- CONCLUSION
- AREAS FOR FUTURE RESEARCH
- Subcommittee on Attention Deficit Hyperactivity Disorder (Oversight by the Steering Committee on Quality Improvement and Management, 2005–2011) Writing Committee
- Consultant
- Staff
- ACKNOWLEDGMENTS
- Footnotes
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics
- Comments
Related Articles
Cited By...
- Pediatric Attention-Deficit/Hyperactivity Disorder in Louisiana: Trends, Challenges, and Opportunities for Enhanced Quality of Care
- Mental Health Competencies for Pediatric Practice
- Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009-2017
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
- ADHD Diagnosis and Treatment Guidelines: A Historical Perspective
- School-aged Children Who Are Not Progressing Academically: Considerations for Pediatricians
- School Readiness in Preschoolers With Symptoms of Attention-Deficit/Hyperactivity Disorder
- Five-Year Outcomes of Behavioral Health Integration in Pediatric Primary Care
- Mental health in elite athletes: International Olympic Committee consensus statement (2019)
- Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look
- Attention-deficit/hyperactivity disorder in elite athletes: a narrative review
- Disrupted reinforcement learning during post-error slowing in ADHD
- Quasi-periodic patterns of brain activity in individuals with Attention-Deficit/Hyperactivity Disorder
- Age at School Entry and ADHD Diagnosis
- The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex
- Maternal Gestational Diabetes Mellitus, Type 1 Diabetes, and Type 2 Diabetes During Pregnancy and Risk of ADHD in Offspring
- Temporal Trends in ADHD Prevalence, 1997-2016
- The Role of Integrated Care in a Medical Home for Patients With a Fetal Alcohol Spectrum Disorder
- Pediatric ADHD Medication Exposures Reported to US Poison Control Centers
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Predictors of Medication Continuity in Children With ADHD
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?
- Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth
- Public Health Literature Review of Fragile X Syndrome
- Value-Based Insurance Design Pharmacy Benefits for Children and Youth With Special Health Care Needs: Principles and Opportunities
- It Takes a Full-Service Village to Treat Children With ADHD
- Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline
- Addressing Early Childhood Emotional and Behavioral Problems
- Understanding attention deficit hyperactivity disorder as a continuum
- Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
- Screening of Neurocognitive and Executive Functioning in Children, Adolescents, and Young Adults With Type 1 Diabetes
- Impact of a Web-Portal Intervention on Community ADHD Care and Outcomes
- Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study
- Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Born Preterm and With Poor Fetal Growth
- Improving Care for Children With ADHD: The Information is Just a Rating Scale Away
- Mediation and Moderation of Outcome in a Training Intervention for Adolescents With Attention-Deficit/Hyperactivity Disorder
- Training Problem Solving and Organizational Skills in Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial
- Practical pharmacotherapy in child psychiatry: an update
- Long-Term Use of Psychiatric Medications in Preschoolers With ADHD
- Timing of the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder
- Pediatric Psychopharmacology for Treatment of ADHD, Depression, and Anxiety
- Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis
- Childhood attention-deficit/hyperactivity disorder
- The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorder
- Variability in ADHD Care in Community-Based Pediatrics
- Overdiagnosis: How Our Compulsion for Diagnosis May Be Harming Children
- Clinical and social factors associated with attention-deficit hyperactivity disorder medication use: population-based longitudinal study
- Small Geographic Area Variations in Prescription Drug Use
- Safety of medicines used for ADHD in children: a review of published prospective clinical trials
- Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder
- Attention-Deficit/Hyperactivity Disorder and Substance Abuse
- Trends in Diagnosis and Treatment of ADHD
- Common and Costly Hospitalizations for Pediatric Mental Health Disorders
- Attention-Deficit/Hyperactivity Disorder in Young Children: Predictors of Diagnostic Stability
- Attention-deficit/hyperactivity disorder: are we helping or harming?
- Association of Constipation and Fecal Incontinence With Attention-Deficit/Hyperactivity Disorder
- A 7-year-old boy experiencing difficulty at school
- Parental Preferences and Goals Regarding ADHD Treatment
- National Trends in Psychotropic Medication Use in Young Children: 1994-2009
- Effect of ADHD Treatment on Injury Rates
- Use of a Computerized Decision Aid for ADHD Diagnosis: A Randomized Controlled Trial
- Do Parent Perceptions Predict Continuity of Publicly Funded Care for Attention-Deficit/Hyperactivity Disorder?
- Clinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders
- Parent Report as Proxy for Teacher Ratings in ADHD
- Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management: A Scientific Statement From the American Heart Association
- What Causes ADHD?
- New AAP Guidelines for ADHD: A Challenge for Primary Care